Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : AZN    crawled date : 2022 - 07 - 25    save search

Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-07-25 (Crawled : 20:00) - prnewswire.com
AZNCF | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: 3.39% H: 0.42% C: -1.6%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 0.47% C: -0.08%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.48% C: 0.17%
ABBV | News | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 1.61% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 1.09% C: 0.23%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 1.66% C: 0.6%

drug global market
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low metastatic breast cancer
Published: 2022-07-25 (Crawled : 12:00) - biospace.com/
AZN | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.39% C: -0.04%

enhertu granted review cancer her2- her2 metastatic breast cancer
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low Metastatic Breast Cancer
Published: 2022-07-25 (Crawled : 11:00) - biospace.com/
AZN | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.39% C: -0.04%

enhertu granted review cancer her2- her2 metastatic breast cancer
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.